Actively hiring
Immunology & Inflammation Therapeutics
Biologics & Biosimilars
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
196
US Form 5500 (plan participants) · Sep 2025
Backers
1
Xontogeny
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

On a mission to transform the future of autoimmune care. Developing innovative therapies with the potential to redefine the standard of…

SFA Therapeutics is developing a next-generation oral immune tolerance therapy for psoriasis. Our investigational approach is designed to…

Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology.

Abivax is a clinical-stage biotechnology company driven to advance human health by regulating the immune response through the power of…

Precision therapy for autoimmune-driven diseases is now within reach. Current treatments for autoimmune diseases are non-specific, often…

We are using a precision approach to develop therapies designed to transform the lives of patients with immune-mediated diseases.
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
San Francisco
United States
HQ
Onsite/San Fransisco
One Letterman Drive, Building B 6th Floor, San Francisco, CA 94129
Boston
United States
Regional office
Onsite/Boston

Xontogeny